Familial Pulmonary Fibrosis: Clinical Trials

6 trials for Familial Pulmonary Fibrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 unknown, 1 active not recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Familial Pulmonary Fibrosis: new trials by email Literature Review of Familial Pulmonary Fibrosis trials Research Report on Familial Pulmonary Fibrosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hereditary Influences on Pulmonary Fibrosis Trajectories
Interstitial Lung Disease Due to Systemic Disease (Telomere Biology Disorder), Idiopathic Pulmonary Fibrosis (IPF)
Active not recruitingIstituto Clinico Humanitas2502026-04-012026-05-12
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
Nerandomilast, Placebo - Familial Pulmonary Fibrosis, Interstitial Lung Abnormalities
Phase 3RecruitingBoehringer Ingelheim802026-02-102026-09-30
GEN-FPF: Genetic Exploration of Familial Pulmonary Fibrosis
Familial Pulmonary Fibrosis
RecruitingFondazione IRCCS Policlinico San Matteo di Pavia1262025-09-172025-11-26
Clinical Genetics and Screening for Idiopathic Pulmonary Fibrosis
High resolution Computed Tomography (HRCT) scans of the Chest, Pulmonary Function Testing (PFTs), Digital lung sounds auscultation - Familial Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis
UnknownFondazione Policlinico Universitario Agostino Gemelli IRCCS6002024-09-012024-07-25
Mechanisms of Familial Pulmonary Fibrosis
Familial Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis
RecruitingVanderbilt University Medical Center7502009-01-012025-12-31
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis
UnknownNational Jewish Health80002008-07-012020-09-14

Narrower conditions

Idiopathic Pulmonary Fibrosis (4)  ·  Lung Diseases, Interstitial (2)  ·  Idiopathic Interstitial Pneumonias (1)  ·  Pulmonary Fibrosis (1)

Broader conditions

Lung Diseases (5)  ·  Respiratory Tract Diseases (5)  ·  Lung Diseases, Interstitial (3)  ·  Pulmonary Fibrosis (3)  ·  Fibrosis (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

BI 1015550 (1)  ·  Respiratory Function Tests (1)  ·  Sequence Analysis, DNA (1)

Sponsors

Boehringer Ingelheim (1)  ·  Fondazione IRCCS Policlinico San Matteo di Pavia (1)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)  ·  Istituto Clinico Humanitas (1)  ·  National Jewish Health (1)  ·  Vanderbilt University Medical Center (1)

Countries

Italy (3)  ·  United States (3)  ·  Argentina (1)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Iceland (1)  ·  Japan (1)  ·  Netherlands (1)  ·  South Korea (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

David A. Schwartz, MD (1)  ·  Francesco Amati, MD (1)  ·  Margaret Salisbury, MD (1)

NIH funding

2025 (1)